Association between DNA methylation and coronary heart disease or other atherosclerotic events: a systematic review. Alba Fernández-Sanlés1,2, Sergi Sayols-Baixeras1,2,3, Isaac Subirana1,4, Irene R Degano1,3, Roberto Elosua1,3 Running title: DNA methylation and coronary heart disease 1.-Cardiovascular Epidemiology and Genetics Research Group, REGICOR Study group, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Catalonia, Spain. 2.-Universitat Pompeu Fabra (UPF), Barcelona, Catalonia, Spain. 3.-CIBER Cardiovascular Diseases (CIBERCV), Barcelona, Catalonia, Spain. 4.-CIBER Epidemiology and Public Health (CIBERESP), Barcelona, Catalonia, Spain Author for correspondence: Roberto Elosua, MD, PhD IMIM, Hospital del Mar Medical Research Institute Dr Aiguader 88, 08003 Barcelona, Catalonia, Spain Telephone: (+34) 933 160800; Email:
[email protected] Word count: 6,581 Total number of Figures and Tables: 1 Figure, 5 Tables References: 85 Supplementary material: 4 Figures, 6 Tables 1 ABSTRACT Background and aims: The aim of this study was to perform a systematic review of the association between DNA methylation and coronary heart disease (CHD) or related atherosclerotic traits. Methods: A systematic review was designed. The condition of interest was DNA methylation, and the outcome was CHD or other atherosclerosis-related traits. Three DNA methylation approaches were considered: global methylation, candidate-gene, and epigenome-wide association studies (EWAS). A functional analysis was undertaken using the Ingenuity Pathway Analysis software. Results: In total, 51 articles were included in the analysis: 12 global methylation, 34 candidate-gene and 11 EWAS, with six studies using more than one approach. The results of the global methylation studies were inconsistent. The candidate-gene results were consistent for some genes, suggesting that hypermethylation in ESRα, ABCG1 and FOXP3 and hypomethylation in IL-6 were associated with CHD.